Results 281 to 290 of about 208,301 (303)

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

Cancer Cell, 2018
Mark A Merchant, Eva Lin, Joachim Rudolph   +2 more
exaly  

Targeting the untargetable KRAS in cancer therapy

Acta Pharmaceutica Sinica B, 2019
Xin Li
exaly  

KRAS ausbremsen

Im Focus Onkologie, 2013
openaire   +1 more source

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Cancer Cell, 2018
Devon R Blake, Thomas S K Gilbert, Prson Gautam   +2 more
exaly  

High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells

Cell Metabolism, 2019
Chun-Mei Hu, Yung-Ming Jeng, Yu-Ting Chang   +2 more
exaly  

Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma

Cancer Cell, 2016
Verline Justilien, Nicole R Murray, Alan P Fields   +2 more
exaly  

C-KRAS

2016
openaire   +1 more source

Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma

Proceedings of the National Academy of Sciences of the United States of America, 2017
Arvin M Gouw, Livia S Eberlin, Katherine Margulis   +2 more
exaly  

KRAS

openaire   +1 more source

Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

Cancer Cell, 2018
Ting Chen, Laura Gutierrez Quiceno, Shoichiro Tange   +2 more
exaly